PUBLICATIONS INTERNATIONALES 2010 1 Afonso PV, Mekaouche M, Mortreux F, Toulza F, Moriceau A, Wattel E, Gessain A, Bangham CR, Dubreuil G, Plumelle Y, Hermine O, Estaquier J, Mahieux R (2010) Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood 116: 3802-3808 2 Alapetite C, Brisse H, Patte C, Raquin MA, Gaboriaud G, Carrie C, Habrand JL, Thiesse P, Cuilliere JC, Bernier V, Ben Hassel M, Frappaz D, Baranzelli MC, Bouffet E (2010) Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol 12: 1318-1325 3 Alexandre J, Ray-Coquard I, Selle F, Floquet A, Cottu P, Weber B, Falandry C, Lebrun D, Pujade-Lauraine E (2010) Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience. Ann Oncol 21: 2377-2381 4 Alfano L, Guida T, Provitera L, Vecchio G, Billaud M, Santoro M, Carlomagno F (2010) RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block. J Clin Endocrinol Metab 95: 35523557 5 Annereau JP, Brel V, Dumontet C, Guminski Y, Imbert T, Broussas M, Vispe S, Breand S, Guilbaud N, Barret JM, Bailly C (2010) A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leuk Res 34: 1383-1389 6 Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A (2010) TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29: 3173-3184 7 Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk JU, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernstrom H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Duran M, Tejada MI, Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S, Godwin AK, StoppaLyonnet D, de PA, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frenay M, Venat-Bouvet L, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jonson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E, Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L, Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel C, Meindl A, Lochmann M, Arnold N, Heidemann S, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Kast K, Schonbuchner I, Caldes T, de la Hoya M, Aittomaki K, Nevanlinna H, Simard J, Spurdle AB, Holland H, Chen X, Platte R, Chenevix-Trench G, Easton DF (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70: 9742-9754 8 Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P, Hogervorst FB, Rookus MA, Jager A, van den OA, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer H, Gomez Garcia EB, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Gorski B, Cybulski C, Spurdle AB, Holland H, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, PreislerAdams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R, Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C, Loman N, Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A, Radice P, Caldes T, de la HM, Singer CF, Fink-Retter A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM, Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus SJ, Gayther SA, Phelan C, Narod S, Szabo CI, Benitez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA, Beattie MS, Hamann U, Godwin AK, Montagna M, Casella C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J, Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A, Rennert G, Martin NG, Montgomery GW, Chang-Claude J, Flesch-Janys D, Brauch H, Severi G, Baglietto L, Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos SS, I, Peto J, Lambrechts D, Paridaens R, Rudiger T, Forsti A, Winqvist R, Pylkas K, Diasio RB, Lee AM, 2 Eckel-Passow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892 9 Arnaud O, Koubeissi A, Ettouati L, Terreux R, Alame G, Grenot C, Dumontet C, Di PA, Paris J, Falson P (2010) Potent and fully noncompetitive peptidomimetic inhibitor of multidrug resistance P-glycoprotein. J Med Chem 53: 6720-6729 10 Autier P, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson JG, Olafsson JH, Byrnes GB, Hery C, Dore JF, Boniol M (2010) Autier et al. Respond to "A Sunbed Epidemic?". Am J Epidemiol 11 Bachelard-Cascales E, Chapellier M, Delay E, Pochon G, Voeltzel T, Puisieux A, Caron dF, Maguer-Satta V (2010) The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells 28: 1081-1088 12 Banneau G, Guedj M, Macgrogan G, de M, I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M (2010) Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res 12: R63 13 Bastid J, Bouchet BP, Ciancia C, Pourchet J, Audoynaud C, Grelier G, Puisieux A, Ansieau S (2010) The SNAIL family member SCRATCH1 is not expressed in human tumors. Oncol Rep 23: 523-529 14 Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O, Pallusseau L, Carnin C, Laine K, Schlama A, Thiebaut A, Patru MC, Bauchet F, Lionnet M, Wager M, Faillot T, Taillandier L, Figarella-Branger D, Capelle L, Loiseau H, Frappaz D, Campello C, Kerr C, Duffau H, Reme-Saumon M, Tretarre B, Daures JP, Henin D, Labrousse F, Menei P, Honnorat J (2010) Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 15 Belbaraka R, Tredan O, Ray-Coquard I, Chvetzoff G, Bajard A, Perol D, Ismaili N, Ismaili M, Errihani H, Bachelot T, Rebattu P (2010) Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer. BMC Res Notes 3: 164 16 Benjamin RS, Schoffski P, Hartmann JT, Van Oosterom A, Bui BN, Duyster J, Schuetze S, Blay JY, Reichardt P, Rosen LS, Skubitz K, McCoy S, Sun YN, Stepan DE, Baker L (2010) Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors. Cancer Chemother Pharmacol 3 17 Berthier-Vergnes O, Kharbili ME, de la Fouchardiere A, Pointecouteau T, Verrando P, Wierinckx A, Lachuer J, Le NF, Lamartine J (2010) Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion. Br J Cancer 18 Bertrand A, Marec-Berard P, Raverot G, Trouillas J, Marabelle A (2010) Cabergoline therapy of paraneoplastic Cushing syndrome in children. Pediatr Blood Cancer 55: 589-590 19 Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G, Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J, Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D, Fert V, Birnbaum D, Viens P (2010) Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 20 Billaud M, Viollet B (2010) Close encounters of a novel kind: A multi-targeted cancer drug meets a metabolic sensor. Cancer Biol Ther 10: 21 Blay JY (2010) Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib. Ann Oncol 21: 208-215 22 Blay JY (2010) Updating progress in sarcoma therapy with mTOR inhibitors. Ann Oncol 23 Blay JY, von Mehren M, Blackstein ME (2010) Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer 116: 51265137 24 Bodard AG, Paris M, Salino S, Fortin T (2010) Evaluation of two noninvasive repositioning systems for computer-assisted oral implant surgery in oral cancer patients. Int J Prosthodont 23: 463-468 25 Boisseau N, Burde A, Bachmann P, Senesse P, Hebuterne X (2010) A telephonelinked computer system for home enteral nutrition. J Telemed Telecare 16: 363367 26 Boivin A, Currie K, Fervers B, Gracia J, James M, Marshall C, Sakala C, Sanger S, Strid J, Thomas V, van der WT, Grol R, Burgers J (2010) Patient and public involvement in clinical guidelines: international experiences and future perspectives. Qual Saf Health Care 19: e22 27 Bonaiti B, Bonadona V, Perdry H, Andrieu N, Bonaiti-Pellie C (2010) Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method. Eur J Hum Genet 28 Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, Rousseau R, Combaret V, Benard J, Tauszig-Delamasure S, Mehlen 4 P (2010) Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. J Clin Invest 120: 850-858 29 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L (2010) AGREE II: Advancing guideline development, reporting, and evaluation in health care. Prev Med 51: 421-424 30 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L (2010) AGREE II: Advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 63: 1308-1311 31 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L (2010) AGREE II: Advancing guideline development, reporting and evaluation in health care. CMAJ 182: E839-E842 32 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ 182: 1045-1052 33 Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Hanna SE, Makarski J (2010) Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ 182: E472-E478 34 Buiret G, Combe C, Favrel V, Pommier P, Martin L, Ecochard R, Fayette J, Tartas S, Ramade A, Ceruse P (2010) A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 77: 430-437 35 Butturini A, Frappaz D (2010) The challenges of high-dose chemotherapy in CNS tumors. Pediatr Blood Cancer 54: 652-653 36 Campone M, Juin P, Andre F, Bachelot T (2010) Resistance to HER2 inhibitors: Is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation. Crit Rev Oncol Hematol 37 Carrabin N, Mithieux F, Meeus P, Tredan O, Guastalla JP, Bachelot T, Labidi SI, Treilleux I, Rivoire M, Ray-Coquard I (2010) Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer. Bull Cancer 97: E23-E32 5 38 Casali PG, Blay JY (2010) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 Suppl 5: v98-102 39 Casali PG, Blay JY (2010) Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 Suppl 5: v198v203 40 Cassier PA, Blay JY (2010) Imatinib mesylate for the treatment of gastrointestinal stromal tumor. Expert Rev Anticancer Ther 10: 623-634 41 Cassier PA, Blay JY (2010) Molecular response prediction in gastrointestinal stromal tumors. Target Oncol 5: 29-37 42 Cassier PA, Ducimetiere F, Lurkin A, Ranchere-Vince D, Scoazec JY, Bringuier PP, Decouvelaere AV, Meeus P, Cellier D, Blay JY, Ray-Coquard I (2010) A prospective epidemiological study of new incident GISTs during two consecutive years in Rhone Alpes region: incidence and molecular distribution of GIST in a European region. Br J Cancer 103: 165-170 43 Castets M, Mehlen P (2010) Netrin-1 role in angiogenesis: To be or not to be a pro-angiogenic factor? Cell Cycle 9: 44 Chargui J, Combaret V, Scaglione V, Iacono I, Peri V, Valteau-Couanet D, Dubrel M, Angevin E, Puisieux A, Romagne F, Bergeron C (2010) Bromohydrin pyrophosphate-stimulated Vgamma9delta2 T cells expanded ex vivo from patients with poor-prognosis neuroblastoma lyse autologous primary tumor cells. J Immunother 33: 591-598 45 Charles J, Di DJ, Salameire D, Bendriss-Vermare N, Aspord C, Muhammad R, Lefebvre C, Plumas J, Leccia MT, Chaperot L (2010) Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor. J Invest Dermatol 130: 1646-1656 46 Chatagnon A, Ballestar E, Esteller M, Dante R (2010) A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene. PLoS One 5 (3): e9665 47 Chenot J, Melodelima D, N'djin WA, Souchon R, Rivoire M, Chapelon JY (2010) Intra-operative ultrasound hand-held strain imaging for the visualization of ablations produced in the liver with a toroidal HIFU transducer: first in vivo results. Phys Med Biol 55: 3131-3144 48 Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, VinceRanchere D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A (2010) Validated prediction of clinical outcome in sarcomas and multiple types of 6 cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16: 781-787 49 Cimarelli S, Lachenal F, Ricard F, Chassagne-Clement C, Heudel PE, Janody P, Sebban C (2010) A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging. Clin Nucl Med 35: 425-427 50 Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G, Kaltenbach S, Yakouben K, Mazingue F, Robert A, Boutard P, Plantaz D, Rohrlich P, van Vlierberghe P, Preudhomme C, Otten J, Speleman F, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Cave H (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 24: 2023-2031 51 Cohen S, Jordheim LP, Megherbi M, Dumontet C, Guitton J (2010) Liquid chromatographic methods for the determination of endogenous nucleotides and nucleotide analogs used in cancer therapy: a review. J Chromatogr B Analyt Technol Biomed Life Sci 878: 1912-1928 52 Coiffier B, Thieblemont C, Van den NE, Lepeu G, Plantier I, Castaigne S, Lefort S, Marit G, Macro M, Sebban C, Belhadj K, Bordessoule D, Ferme C, Tilly H (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 116: 2040-2045 53 Cortes J, Vahdat L, Blum JL, Twelves C, Campone M, Roche H, Bachelot T, Awada A, Paridaens R, Goncalves A, Shuster DE, Wanders J, Fang F, Gurnani R, Richmond E, Cole PE, Ashworth S, Allison MA (2010) Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine. J Clin Oncol 28: 3922-3928 54 Cosset E, Hamdan G, Jeanpierre S, Voeltzel T, Sagorny K, Hayette S, Mahon FX, Dumontet C, Puisieux A, Nicolini FE, Maguer-Satta V (2010) Deregulation of TWIST-1 in the CD34+ compartment represents a novel prognostic factor in chronic myeloid leukemia (CML). Blood 55 Cutuli B, Le Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y (2010) Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 73: 246-254 56 David M, Wannecq E, Descotes F, Jansen S, Deux B, Ribeiro J, Serre CM, Gres S, Bendriss-Vermare N, Bollen M, Saez S, Aoki J, Saulnier-Blache JS, Clezardin 7 P, Peyruchaud O (2010) Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts. PLoS One 5: e9741 57 de Brito C, Tomkowiak M, Ghittoni R, Caux C, Leverrier Y, Marvel J (2010) CpG Promotes Cross-Presentation of Dead Cell-Associated Antigens by PreCD8{alpha}+ Dendritic Dells. J Immunol 58 de la Fouchardière C, Négrier S, Labrosse H, Martel L, I, Desseigne F, Meeus P, Tavan D, Petit-Laurent F, Rivoire M, Perol D, Carrie C (2010) Phase I study of daily irinotecan as a radiation sensitizer for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 77: 409-413 59 de la Grange P, Gratadou L, Delord M, Dutertre M, Auboeuf D (2010) Splicing factor and exon profiling across human tissues. Nucleic Acids Res 38: 2825-2838 60 Delay E, Sinna R, Chekaroua K, Delaporte T, Garson S, Toussoun G (2010) Lipomodeling of Poland's syndrome: a new treatment of the thoracic deformity. Aesthetic Plast Surg 34: 218-225 61 Desgranges FP, Steghens A, Mithieux F, Rosay H (2010) Potential risks of thoracic epidural analgesia in hyperthermic intraperitoneal chemotherapy. J Surg Oncol 101: 442 62 Domont J, Salas S, Lacroix L, Brouste V, Saulnier P, Terrier P, Ranchere D, Neuville A, Leroux A, Guillou L, Sciot R, Collin F, Dufresne A, Blay JY, Le Cesne A, Coindre JM, Bonvalot S, Benard J (2010) High frequency of betacatenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Br J Cancer 102: 1032-1036 63 Dore JF, Boniol M, Telle-Lamberton M (2010) Re: Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst 102: 741-742 64 Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannucci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Le ML, Lund E, Peeters PH, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler RG, Cox DG (2010) PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 31: 455-461 65 Dreux N, Marty M, Chibon F, Velasco V, Hostein I, Ranchere-Vince D, Terrier P, Coindre JM (2010) Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases. Mod Pathol 23 : 1657-1666 8 66 du BA, Reuss A, Harter P, Pujade-Lauraine E, Ray-Coquard I, Pfisterer J (2010) Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol 28: 1733-1739 67 Dufresne A, Bertucci F, Penel N, Le Cesne A, Bui B, Tubiana-Hulin M, RayCoquard I, Cupissol D, Chevreau C, Perol D, Goncalves A, Jimenez M, Bringuier PP, Blay JY (2010) Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. Br J Cancer 103: 482-485 68 Dumontet C, Jordan MA (2010) Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9: 790-803 69 Dumontet C, Krajewska M, Treilleux I, Mackey JR, Martin M, Rupin M, Lafanechere L, Reed JC (2010) BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapy. Clin Cancer Res 16: 3988-3997 70 Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D (2010) Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer. Cancer Res 70: 3760-3770 71 Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D (2010) Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res 70: 896-905 72 Dutertre M, Sanchez G, De Cian MC, Barbier J, Dardenne E, Gratadou L, Dujardin G, Le Jossic-Corcos C, Corcos L, Auboeuf D (2010) Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 17: 13581366 73 Dutertre M, Vagner S, Auboeuf D (2010) Alternative splicing and breast cancer. RNA Biol 7 (4): 403-411 74 Egevad L, Valdman A, Wiklund NP, Seve P, Dumontet C (2010) Beta-tubulin III expression in prostate cancer. Scand J Urol Nephrol 44: 371-377 75 Fayette J, Boyle H, Chabaud S, Favier B, Engel C, Cassier P, Thiesse P, Meeus P, Sunyach MP, Vaz G, Ray-Coquard I, Ranchere D, Decouvelaere AV, Alberti L, Perol D, Blay JY (2010) Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution. Anticancer Drugs 21: 113-119 76 Fayette J, Montella A, Chabaud S, Bachelot T, Pommier P, Girodet D, Racadot S, Montbarbon X, Favier B, Zrounba P (2010) Paclitaxel is effective in relapsed head and neck squamous cell carcinoma: a retrospective study of 66 patients at a single institution. Anticancer Drugs 21: 553-558 9 77 Fervers B, Carretier J, Bataillard A (2010) Clinical practice guidelines. J Visc Surg 147: e341-e349 78 Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G (2010) Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-andneck cancer: results of GORTEC Phase II study. Int J Radiat Oncol Biol Phys 76: 154-163 79 Flechon A, Tavernier E, Boyle H, Meeus P, Rivoire M, Droz JP (2010) Longterm oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. BJU Int 106: 779-785 80 Fougere M, Gaudineau B, Barbier J, Guaddachi F, Feugeas JP, Auboeuf D, Jauliac S (2010) NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene 29: 2292-2301 81 Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segre AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars M, Sobol H, Longy M, Frenay M, GEMO SC, Hogervorst FB, Rookus MA, Collee JM, Hoogerbrugge N, van Roozendaal KE, Piedmonte M, Rubinstein W, Nerenstone S, Van LL, Blank SV, Caldes T, de la Hoya M, Nevanlinna H, Aittomaki K, Lazaro C, Blanco I, Arason A, Johannsson OT, Barkardottir RB, Devilee P, Olopade OI, Neuhausen SL, Wang X, Fredericksen ZS, Peterlongo P, Manoukian S, Barile M, Viel A, Radice P, Phelan CM, Narod S, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, Toland AE, Montagna M, D'Andrea E, Friedman E, Laitman Y, Borg A, Beattie M, Ramus SJ, Domchek SM, Nathanson KL, Rebbeck T, Spurdle AB, Chen X, Holland H, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Overeem Hansen TV, Nielsen FC, Greene MI, Mai PL, Osorio A, Duran M, Andres R, Benitez J, Weitzel JN, Garber J, Hamann U, Peock S, Cook M, Oliver C, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Walker L, Eason J, Barwell J, Godwin AK, Schmutzler RK, Wappenschmidt B, Engert S, Arnold N, Gadzicki D, Dean M, Gold B, Klein RJ, Couch FJ, Chenevix-Trench G, Easton DF, Daly MJ, Antoniou AC, Altshuler DM, Offit K, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Gauthier-Villars M, Sobol H, Longy M, Frenay M, Sinilnikova O, Barjhoux L, Giraud S, Leone M, Mazoyer S, Stoppa-Lyonnet D, Gauthier-Villars M, Houdayer C, Moncoutier V, Belotti M, de PA, Bressac-de-Paillerets B, Remenieras A, Byrde V, Caron O, Lenoir G, Bignon YJ, Uhrhammer N, Lasset C, Bonadona V, Hardouin A, Berthet P, Sobol H, Bourdon V, Noguchi T, Eisinger F, Coulet F, Colas C, Soubrier F, Coupier I, Peyrat JP, Fournier J, Revillion F, Vennin P, Adenis C, Rouleau E, Lidereau R, Demange L, Nogues C, Muller D, Fricker JP, Longy M, Sevenet N, Toulas C, Guimbaud R, Gladieff L, Feillel V, Leroux D, Dreyfus H, Rebischung C, Cassini C, Faivre L, Prieur F, Ferrer SF, Frenay M, Venat-Bouvet L, Lynch HT, Hogervorst FB, Rookus MA, Collee JM, Hoogerbrugge N, van 10 Roozendaal KE, Hogervorst FB, Verhoef S, Verheus M, van 't Veer LJ, van Leeuwen FE, Rookus MA, Collee M, van den Ouweland AM, Jager A, Hooning MJ, Tilanus-Linthorst MM, Seynaeve C, van Asperen CJ, Wijnen JT, Vreeswijk MP, Tollenaar RA, Devilee P, Ligtenberg MJ, Hoogerbrugge N, Ausems MG, van der Luijt RB, Aalfs CM, van Os TA, Gille JJ, Waisfisz Q, Meijers-Heijboer H, Gomez-Garcia EB, van Roozendaal CE, Blok MJ, Oosterwijk JC, van der Hout AH, Mourits MJ, Vasen HF, Spurdle AB, Chenevix-Trench G (2010) Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 6: e1001183 82 Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Dore JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schuz J, Tucker MA, Volkmer B, Breitbart E (2010) A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol 34: 355-358 83 Gerard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M (2010) Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model. Pharm Res 27: 26022613 84 Ghayad SE, Cohen PA (2010) Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients. Recent Pat Anticancer Drug Discov 5: 29-57 85 Ghayad SE, Vendrell JA, Larbi SB, Dumontet C, Bieche I, Cohen PA (2010) Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways. Int J Cancer 126: 545-562 86 Ghesquieres H, Ferlay C, Sebban C, Perol D, Bosly A, Casasnovas O, Reman O, Coiffier B, Tilly H, Morel P, Van den NE, Colin P, Haioun C, Biron P, Blay JY (2010) Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA). Ann Oncol 21: 842-850 87 Giacchero D, Maire G, Nuin PA, Berthier F, Ebran N, Carlotti A, Celerier P, Coindre JM, Esteve E, Fraitag S, Guillot B, Ranchere-Vince D, Saiag P, Terrier P, Lacour JP, Pedeutour F (2010) No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans. J Invest Dermatol 130: 904-907 88 Giard S, Chauvet MP, Penel N, Mignotte H, Martel P, Tunon dL, Gimbergues P, Dessogne P, Classe JM, Fondrinier E, Marmousez T (2010) Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a 11 French prospective multi-institutional study (IGASSU 0502). Ann Oncol 21: 1630-1635 89 Goldschneider D, Mehlen P (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29: 1865-1882 90 Gouas DA, Shi H, Hautefeuille AH, Ortiz-Cuaran SL, Legros PC, Szymanska KJ, Galy O, Egevad LA, Abedi-Ardekani B, Wiman KG, Hantz O, Caron dF, Chemin IA, Hainaut PL (2010) Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein. Carcinogenesis 31: 1475-1482 91 Goutelle S, Larcher R, Padoin C, Mialou V, Bleyzac N (2010) Oral voriconazole dose in children: one size does not fit all. Clin Infect Dis 51: 870 92 Gronchi A, Blay JY, Trent JC (2010) The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor. Cancer 116: 18471858 93 Guilcher MA, Prevost B, Sunyach MP, Peiffert D, Maingon P, Thomas L, Williaume D, Begue M, Lerouge D, Campion L, Mahe MA (2010) High-DoseRate Brachytherapy for Non-Small-Cell Lung Carcinoma: A Retrospective Study of 226 Patients. Int J Radiat Oncol Biol Phys 94 Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C (2010) Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells. BMC Cancer 10: 135 95 Harrison MB, Legare F, Graham ID, Fervers B (2010) Adapting clinical practice guidelines to local context and assessing barriers to their use. CMAJ 182: E78E84 96 Heritier S, Le Merrer M, Jaubert F, Bigorre M, Gillibert-Yvert M, de Court, Ziade M, Bertrand Y, Carrie C, Chastagner P, Bost-Bru C, Leonard JC, Ouache M, Boccon-Gibod L, Mary P, de Blic J, Pin I, Wendling D, Revillon Y, Houdoin V, Forin V, Lepointe HD, Languepin J, Wagnon J, Epaud R, Fauroux B, Donadieu J (2010) Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009. Orphanet J Rare Dis 5: 3 97 Hery C, Tryggvadottir L, Sigurdsson T, Olafsdottir E, Sigurgeirsson B, Jonasson JG, Olafsson JH, Boniol M, Byrnes GB, Dore JF, Autier P (2010) A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol 172: 762767 98 Heudel P, Biston MC, Fayette J, Ramade A, Gassa F, Pommier P (2010) Head and neck sarcoma: report of a case treated by intensity-modulated radiation therapy. Int J Clin Oncol 15: 305-309 12 99 Heudel P, Cimarelli S, Montella A, Bouteille C, Mognetti T (2010) Value of PETFDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors. Int J Clin Oncol 15 : 588-593 100 Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D (2010) Impaired Tolllike receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends Immunol 31: 391-397 101 Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabe RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MM, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SO, Joly Y, Kato K, Kennedy KL, Nicolas P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Clement B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van d, V, Futreal PA, Aburatani H, Bayes M, Botwell DD, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, Lopez-Otin C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guigo R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, Lopez-Bigas N, Luo R, Muthuswamy L, Ouellette BF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guigo R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, Lopez-Bigas N, Ouellette BF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SO, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cross A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DR, Hasel KW, Joly Y, Kaan TS, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicolas P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DD, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BA, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao MS, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhlen M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, Borresen-Dale AL, Caldas C, Foekens JA, Martin S, ReisFilho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van d, V, van't 13 Veer L, Calvo F (2010) International network of cancer genome projects. Nature 464: 993-998 102 Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, AbdelRahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Durr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11: 561-570 103 Italiano A, Delva F, Mathoulin-Pelissier S, Le Cesne A, Bonvalot S, Terrier P, Trassard M, Michels JJ, Blay JY, Coindre JM, Bui B (2010) Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database. Ann Oncol 21 : 2436-2441 104 Joha S, Dauphin V, Lepretre F, Corm S, Nicolini FE, Roumier C, Nibourel O, Grardel N, Maguer-Satta V, Idziorek T, Figeac M, Lai JL, Quesnel B, Etienne G, Guilhot F, Lippert E, Preudhomme C, Roche-Lestienne C (2010) Genomic characterization of Imatinib resistance in CD34(+) cell populations from chronic myeloid leukaemia patients. Leuk Res 105 Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel D, Vendrell JA, Dumontet C (2010) Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. Cancer Chemother Pharmacol 106 Julian-Reynier C, Bouhnik AD, Mouret-Fourme E, Gauthier-Villars M, Berthet P, Lasset C, Fricker JP, Caron O, Gesta P, Luporsi E, Faivre L, Longy M, Gladieff L, Frenay M, Dreyfus H, Sobol H, Vennin P, Nogues C (2010) Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genet Med 12: 801-807 107 Kaufman B, Wu Y, Amonkar MM, Sherrill B, Bachelot T, Salazar V, Viens P, Johnston S (2010) Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer. Curr Med Res Opin 26: 1065-1073 108 Kieran MW, Walker D, Frappaz D, Prados M (2010) Brain tumors: From childhood through adolescence into adulthood. J Clin Oncol 28 :4783-4789 109 Knaapen L, Cazeneuve H, Cambrosio A, Castel P, Fervers B (2010) Pragmatic evidence and textual arrangements: a case study of French clinical cancer guidelines. Soc Sci Med 71: 685-692 110 Kogan-Sakin I, Tabach Y, Buganim Y, Molchadsky A, Solomon H, Madar S, Kamer I, Stambolsky P, Shelly A, Goldfinger N, Valsesia-Wittmann S, Puisieux A, Zundelevich A, Gal-Yam EN, Avivi C, Barshack I, Brait M, Sidransky D, 14 Domany E, Rotter V (2010) Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. Cell Death Differ 111 Lachenal F, Sebban C, Duruisseaux M, Biron P, Blay JY, Ghesquieres H (2010) Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single center. Bull Cancer 97: E33-E36 112 Larouche JF, Berger F, Chassagne-Clement C, Ffrench M, Callet-Bauchu E, Sebban C, Ghesquieres H, Broussais-Guillaumot F, Salles G, Coiffier B (2010) Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J Clin Oncol 28: 2094-2100 113 Le Cesne A, Blay JY, Bui BN, Bouche O, Adenis A, Domont J, Cioffi A, RayCoquard I, Lassau N, Bonvalot S, Moussy A, Kinet JP, Hermine O (2010) Phase II study of oral masitinib mesilate in imatinib-naive patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). Eur J Cancer 46: 1344-1351 114 Le Cesne A, Ray-Coquard I, Bui BN, Adenis A, Rios M, Bertucci F, Duffaud F, Chevreau C, Cupissol D, Cioffi A, Emile JF, Chabaud S, Perol D, Blay JY (2010) Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncol 11: 942-949 115 Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, Sentis S, Corbo L (2010) Methylation, a key step for nongenomic estrogen signaling in breast tumors. Steroids 75: 560-564 116 Liberelle B, Bartholin L, Boucher C, Murschel F, Jolicoeur M, Durocher Y, Merzouki A, De CG (2010) New ELISA approach based on coiled-coil interactions. J Immunol Methods 362: 161-167 117 Lurkin A, Ducimetiere F, Vince DR, Decouvelaere AV, Cellier D, Gilly FN, Salameire D, Biron P, de Laroche G, Blay JY, Ray-Coquard I (2010) Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region. BMC Cancer 10: 150 118 Marabelle A, Bergeron C, Billaud G, Mekki Y, Girard S (2010) Hemophagocytic syndrome revealing primary HHV-6 infection. J Pediatr 157: 511 119 Mastrangelo G, Fadda E, Cegolon L, Montesco MC, Ray-Coquard I, Buja A, Fedeli U, Frasson A, Spolaore P, Rossi CR (2010) A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health 10: 188 120 Maucort-Boulch D, Baron MH, Pommier P, Weber DC, Mizoe JE, Rochat J, Boissel JP, Balosso J, Tsujii H, Amsallem E (2010) Rationale for carbon ion 15 therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials. Cancer Radiother 14: 34-41 121 Mazeron R, Etienne-Mastroianni B, Perol D, Arpin D, Vincent M, Falchero L, Martel-Lafay I, Carrie C, Claude L (2010) Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77: 38-43 122 McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C (2010) Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J Cancer 46: 1588-1595 123 Mehlen P, Guenebeaud C (2010) Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22: 46-54 124 Mestrallet G, Bertholet-Thomas A, Ranchin B, Bouvier R, Frappaz D, Cochat P (2010) Recurrence of a dysgerminoma in Frasier syndrome. Pediatr Transplant 125 Monges G, Bisot-Locard S, Blay JY, Bouvier AM, Urbieta M, Coindre JM, Scoazec JY (2010) The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists. Bull Cancer 97: E16-E22 126 Morello LG, Hesling C, Coltri PP, Castilho BA, Rimokh R, Zanchin NI (2010) The NIP7 protein is required for accurate pre-rRNA processing in human cells. Nucleic Acids Res 127 Morschhauser F, Mounier N, Sebban C, Brice P, Solal-Celigny P, Tilly H, Feugier P, Ferme C, Copin MC, Lamy T (2010) Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS). Cancer 116: 4299-4308 128 N'djin WA, Melodelima D, Parmentier H, Rivoire M, Chapelon JY (2010) In vivo preclinical evaluation of the accuracy of toroidal-shaped HIFU treatments using a tumor-mimic model. Phys Med Biol 55: 2137-2154 129 Novelli M, Rossi S, Rodriguez-Justo M, Taniere P, Seddon B, Toffolatti L, Sartor C, Hogendoorn PC, Sciot R, Van Glabbeke M, Verweij J, Blay JY, Hohenberger P, Flanagan A, Dei Tos AP (2010) DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology 57: 259-270 130 Pain S, Dezutter C, Reymermier C, Vogelgesang B, Delay E, Andre V (2010) Age-related changes in pro-opiomelanocortin (POMC) and related receptors in human epidermis. Int J Cosmet Sci 32: 266-275 16 131 Paradisi A, Mehlen P (2010) Netrin-1, a missing link between chronic inflammation and tumor progression. Cell Cycle 9: 132 Paris M, Chaux-Bodard AG, Gourmet R, Fortin T (2010) Guided implant surgery on oral cancer patients: in vitro study. Int J Comput Assist Radiol Surg 133 Pecorelli S, Ray-Coquard I, Tredan O, Colombo N, Parma G, Tisi G, Katsaros D, Lhomme C, Lissoni AA, Vermorken JB, du BA, Poveda A, Frigerio L, Barbieri P, Carminati P, Brienza S, Guastalla JP (2010) Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. Ann Oncol 21: 759-765 134 Penel N, Delord JP, Bonneterre ME, Bachelot T, Ray-Coquard I, Blay JY, Pascal LB, Borel C, Filleron T, Adenis A, Bonneterre J (2010) Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics. Invest New Drugs 28: 76-82 135 Penel N, Le Cesne A, Bui BN, Perol D, Brain EG, Ray-Coquard I, Guillemet C, Chevreau C, Cupissol D, Chabaud S, Jimenez M, Duffaud F, Piperno-Neumann S, Mignot L, Blay JY (2010) Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. Ann Oncol 136 Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, Demaria O, Viaud N, Gauthier L, Blery M, Bonnefoy-Berard N, Morel Y, Tschopp J, Alexopoulou L, Trinchieri G, Paturel C, Caux C (2010) TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 185: 2080-2088 137 Petroianu A, da Silva RG, Nascimento C, V, Alberti LR, da Silva MG (2010) Effect of spleen surgeries on Escherichia coli distribution on the mononuclear phagocytic system. Int J Surg 8: 48-51 138 Peyre M, Cartalat-Carel S, Meyronet D, Ricard D, Jouvet A, Pallud J, Mokhtari K, Guyotat J, Jouanneau E, Sunyach MP, Frappaz D, Honnorat J, Ducray F (2010) Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas. Neuro Oncol 12: 1078-1082 139 Pomel C, Ferron G, Lorimier G, Rey A, Lhomme C, Classe JM, Bereder JM, Quenet F, Meeus P, Marchal F, Morice P, Elias D (2010) Hyperthermic intraperitoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study. Eur J Surg Oncol 36: 589-593 140 Pommier P, Dussart S, Girinsky T, Chabaud S, Lagrange JL, Nguyen TD, Beckendorff V, D'Hombres A, Artignan X, Bondiau PY, Carrie C, Giammarile F 17 (2010) Impact of 18F-Fluoro-2-deoxyglucose Positron Emission Tomography on Treatment Strategy and Radiotherapy Planning for Stage I-II Hodgkin Disease: A Prospective Multicenter Study. Int J Radiat Oncol Biol Phys 141 Pommier P, Lievens Y, Feschet F, Borras JM, Baron MH, Shtiliyanova A, PijlsJohannesma M (2010) Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy. Radiother Oncol 96: 243-249 142 Pommier P, Touboul E, Chabaud S, Dussart S, Le Pechoux C, Giammarile F, Carrie C (2010) Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study. AJR Am J Roentgenol 195: 350-355 143 Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, Traversier S, Vittot M, Simon M, Gekiere JP, Meuric J, Serot F, Falewee MN, Rodrigues I, Senesse P, Vasson MP, Chelle F, Maget B, Antoun S, Bachmann P (2010) Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 102: 966-971 144 Ravaud A, de la Fouchardiere C, Asselineau J, Delord JP, Do CC, Niccoli P, Rodien P, Klein M, Catargi B (2010) Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU. Oncologist 15: 212213 145 Ray-Coquard I, Weber B, Lotz JP, Tournigand C, Provencal J, Mayeur D, Treilleux I, Paraiso D, Duvillard P, Pujade-Lauraine E (2010) Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients. Gynecol Oncol 119: 53-59 146 Reichardt P, Blay JY, Mehren M (2010) Towards global consensus in the treatment of gastrointestinal stromal tumor. Expert Rev Anticancer Ther 10: 221232 147 Renneville A, Kaltenbach S, Clappier E, Collette S, Micol JB, Nelken B, Lepelley P, Dastugue N, Benoit Y, Bertrand Y, Preudhomme C, Cave H (2010) Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies. Leukemia 24: 476-480 148 Rolland D, Ribrag V, Haioun C, Ghesquieres H, Jardin F, Bouabdallah R, Franchi P, Briere J, De Kerviler E, Chassagne-Clement C, Raponi M, Houlgatte R, Jais JP, Thieblemont C (2010) Phase II trial and prediction of response of single agent tipifarnib in patients with relapsed/refractory mantle cell lymphoma: a Groupe d'Etude des Lymphomes de l'Adulte trial. Cancer Chemother Pharmacol 65: 781790 18 149 Rouleau E, Lefol C, Moncoutier V, Castera L, Houdayer C, Caputo S, Bieche I, Buisson M, Mazoyer S, Stoppa-Lyonnet D, Nogues C, Lidereau R (2010) A missense variant within BRCA1 exon 23 causing exon skipping. Cancer Genet Cytogenet 202: 144-146 150 Rubie H, Geoerger B, Frappaz D, Schmitt A, Leblond P, Ndiaye A, Aerts I, Le Deley MC, Gentet JC, Paci A, Chastagner P, Dias N, Djafari L, Pasquet M, Chatelut E, Landman-Parker J, Corradini N, Vassal G (2010) Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. Eur J Cancer 46: 2763-2770 151 Rudant J, Orsi L, Menegaux F, Petit A, Baruchel A, Bertrand Y, Lambilliotte A, Robert A, Michel G, Margueritte G, Tandonnet J, Mechinaud F, Bordigoni P, Hemon D, Clavel J (2010) Childhood Acute Leukemia, Early Common Infections, and Allergy: The ESCALE Study. Am J Epidemiol 172 : 1015-1027 152 Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, Benard J, Forget S, Blanchard C, Domont J, Bonvalot S, Guillou L, Leroux A, MechineNeuville A, Schoffski P, Lae M, Collin F, Verola O, Carbonnelle A, Vescovo L, Bui B, Brouste V, Sobol H, Aurias A, Coindre JM (2010) Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49: 560-568 153 Sarrut D, Vandemeulebroucke J (2010) B-LUT: Fast and low memory B-spline image interpolation. Comput Methods Programs Biomed 99: 172-178 154 Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, Klijanienko J, Couturier J, Pierron G, Mosseri V, Valent A, Auger N, Plantaz D, Rubie H, Valteau-Couanet D, Bourdeaut F, Combaret V, Bergeron C, Michon J, Delattre O (2010) Accumulation of segmental alterations determines progression in neuroblastoma. J Clin Oncol 28: 3122-3130 155 Schoffski P, Blay JY, De Greve J, Brain E, Machiels JP, Soria JC, Sleijfer S, Wolter P, Ray-Coquard I, Fontaine C, Munzert G, Fritsch H, Hanft G, Aerts C, Rapion J, Allgeier A, Bogaerts J, Lacombe D (2010) Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI). Eur J Cancer 46: 2206-2215 156 Schoffski P, Reichardt P, Blay JY, Dumez H, Morgan JA, Ray-Coquard I, Hollaender N, Jappe A, Demetri GD (2010) A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors. Ann Oncol 21: 1990-1998 157 Sinna R, Delay E, Garson S, Delaporte T, Toussoun G (2010) Breast fat grafting (lipomodelling) after extended latissimus dorsi flap breast reconstruction: A 19 preliminary report of 200 consecutive cases. J Plast Reconstr Aesthet Surg 63 : 1769-1777 158 Sinna R, Garson S, Delay E (2010) Lipomodelling or lipomodeling? Breast 19: 434 159 Sinna R, Perignon D, Qassemyar Q, Benhaim T, Dodreanu CN, Berna P, Delay E (2010) Case report. A double thoracodorsal artery perforator flap technique for the treatment of pectus excavatum. Eplasty 10: e34 160 Sinna R, Qassemyar Q, Garson S, Delay E (2010) Fat injection for overcorrected gynaecomastia. J Plast Reconstr Aesthet Surg 63 : 2196-2197 161 Sleijfer S, Ouali M, Van Glabbeke M, Krarup-Hansen A, Rodenhuis S, Le Cesne A, Hogendoorn PC, Verweij J, Blay JY (2010) Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Eur J Cancer 46: 72-83 162 Sudour H, Chastagner P, Claude L, Desandes E, Klein M, Carrie C, Bernier V (2010) Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. Int J Radiat Oncol Biol Phys 76: 867-873 163 Terret C, Albrand G, Moncenix G, Droz JP (2010) Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question. Crit Rev Oncol Hematol 164 Terret C, Droz JP (2010) Editorial. The perception and dissemination of geriatric oncology. Crit Rev Oncol Hematol 75: 43-46 165 Terret C, Perol D, Albrand G, Droz JP (2010) Quality of life in geriatric oncology-An evaluation of standard questionnaires in elderly men with urological malignancies. Crit Rev Oncol Hematol 166 Teyssier C, Le Romancer M, Sentis S, Jalaguier S, Corbo L, Cavailles V (2010) Protein arginine methylation in estrogen signaling and estrogen-related cancers. Trends Endocrinol Metab 21: 181-189 167 Thibert C, Fombonne J (2010) Dependence receptors: Mechanisms of an announced death. Cell Cycle 9: 168 Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11: 275280 20 169 Thuret I, Pondarre C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galacteros F, Simeoni MC, Badens C (2010) Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica 95: 724-729 170 Tredan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, Bachelot T, Guastalla JP, Lallemand Y, Faure C, Perol D, Bachmann P (2010) Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr 29: 187-191 171 Vincent DF, Kaniewski B, Powers SE, Havenar-Daughton C, Marie JC, Wotton D, Bartholin L (2010) A rapid strategy to detect the recombined allele in LSLTbetaRICA transgenic mice. Genesis 48: 559-562 172 Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Houdayer C, Hogervorst FB, Hooning MJ, Ligtenberg MJ, Spurdle A, Chenevix-Trench G, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Domchek SM, Nathanson KL, Rebbeck TR, Singer CF, Gschwantler-Kaulich D, Dressler C, Fink A, Szabo CI, Zikan M, Foretova L, Claes K, Thomas G, Hoover RN, Hunter DJ, Chanock SJ, Easton DF, Antoniou AC, Couch FJ (2010) Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 19: 2886-2897 173 Watkin E, Devouassoux-Shisheboran M, Pedeutour F, Lagarde P, Salle M, Ranchere-Vince D, Baulieux J, Barnoud R (2010) A First Reported Case of Dedifferentiated Liposarcoma of the Esophagus with Molecular Diagnosis. J Gastrointest Cancer 174 You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Flechon A (2010) Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor. Urology 76: 423-429 175 You B, Pollet-Villard M, Fronton L, Labrousse C, Schott AM, Hajri T, Girard P, Freyer G, Tod M, Tranchand B, Colomban O, Ribba B, Raudrant D, Massardier J, Chabaud S, Golfier F (2010) Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias. Ann Oncol 21: 1643-1650 176 Zacharoulis S, Ashley S, Moreno L, Gentet JC, Massimino M, Frappaz D (2010) Treatment and outcome of children with relapsed ependymoma: a multiinstitutional retrospective analysis. Childs Nerv Syst 26: 905-911 21 177 Zahra N, Frisson T, Grevillot L, Lautesse P, Sarrut D (2010) Influence of Geant4 parameters on dose distribution and computation time for carbon ion therapy simulation. Phys Med 26: 202-208 178 Zane L, Sibon D, Jeannin L, Zandecki M, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, Lancon A, Mortreux F, Wattel E (2010) Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo. Retrovirology 7: 17 179 Zane L, Sibon D, Legras C, Lachuer J, Wierinckx A, Mehlen P, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, Lancon A, Mortreux F, Wattel E (2010) Clonal expansion of HTLV-1 positive CD8(+) cells relies on cIAP-2 but not on cFLIP expression. Virology 407 : 341-351 180 Zeinyeh W, Alameh G, Radix S, Grenot C, Dumontet C, Walchshofer N (2010) Design, synthesis and evaluation of progesterone-adenine hybrids as bivalent inhibitors of P-glycoprotein-mediated multidrug efflux. Bioorg Med Chem Lett 20: 3165-3168 22